Chemoinformaics analysis of METHYL 2-[(2-ACETYLOXYPHENYL)METHYL-[2-[(2-ACETYLOXYPHENYL)METHYL-(2-METHOXY-2-OXOETHYL)AMINO]ETHYL]AMINO]ACETATE
Molecular Weight | 500.548 | nRot | 13 |
Heavy Atom Molecular Weight | 468.292 | nRig | 6 |
Exact Molecular Weight | 500.216 | nRing | 2 |
Solubility: LogS | -2.657 | nHRing | 0 |
Solubility: LogP | 2.989 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 2 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 12 |
No. of Oxygen atom | 8 | No. of Arom Bond | 12 |
nHA | 10 | APOL | 73.3734 |
nHD | 0 | BPOL | 45.9386 |
QED | 0.531 |
Synth | 3.837 |
Natural Product Likeliness | 1.844 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.045 |
HIA | 0.01 |
CACO-2 | -4.215 |
MDCK | 0.0000247 |
BBB | 0.965 |
PPB | 0.865186 |
VDSS | 1.279 |
FU | 0.262923 |
CYP1A2-inh | 0.085 |
CYP1A2-sub | 0.529 |
CYP2c19-inh | 0.033 |
CYP2c19-sub | 0.808 |
CYP2c9-inh | 0.072 |
CYP2c9-sub | 0.905 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.751 |
CYP3a4-inh | 0.045 |
CYP3a4-sub | 0.384 |
CL | 10.244 |
T12 | 0.443 |
hERG | 0.005 |
Ames | 0.008 |
ROA | 0.049 |
SkinSen | 0.071 |
Carcinogencity | 0.056 |
EI | 0.958 |
Respiratory | 0.19 |
NR-Aromatase | 0.006 |
Antiviral | Yes |
Prediction | 0.849888 |